Home            Past Issues            About IP            About IAP           Author Information            Subscription            Advertisement              Search  

   
correspondence

Indian Pediatr 2011;48: 571-572

Reply

M Malik and R Nagpal

Email: [email protected] 
 


We would like to thank the author for the interest shown in our article. We were able to access the article mentioned but as no abstract was available, neither was there a link to the full text of the article; hence, the inadvertent error.

The aim of writing this article was to acknowledge the emerging role of sildenafil in neonatology and to encourage colleagues to report use of the drug for all to benefit. We share the authors concern on the lack of an effective system of drug regulation and monitoring. The burden of regulation and off label use of drugs rests with the state and the laws of the land, as much as with the conscience of the practising physician. However we agree that there should be some regulation to check and ensure safety of newborn care, our article clearly discourages the use of sildenafil by the individual practitioner other than in a research setting.
 

 

Copyright© 1999 by the Indian Pediatrics (Disclaimer)